Trofinetide Scalable Manufacturing via Silylation Technology
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing compositions containing trofinetide are difficult to scale to commercial quantities.
Innovation Solution
The use of silylation technology to manufacture trofinetide and other compounds, allowing for the production of new compositions and larger quantities, thereby addressing the scalability issues of existing methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods are used to produce trofinetide compositions, then the compositions can be manufactured, but the production cannot be scaled to commercial quantities
Solution Approach 1:
The patent changes the chemical parameters of the synthesis method by introducing silylation technology with specific reagents (TMSCl, TMSBr, TMSOTf) and controlling reaction conditions (temperature, solvent selection, stoichiometry) to enable scalable production of trofinetide at commercial quantities while maintaining composition integrity
Solution Approach 2:
The patent uses silylating agents as intermediaries to facilitate the peptide coupling reaction between amino acid components, enabling more efficient and scalable synthesis compared to direct coupling methods, thereby increasing production quantity and scalability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of commercially beneficial compositions, kits, and products containing trofinetide, which are effective in treating neurodegenerative conditions, autism spectrum disorders, and neurodevelopmental disorders.
Implementation Method 1
Use of this new strategy provides for new compositions and substantially larger quantities of trofinetide to be produced
Implementation Method 2
coupling H-MePro-OH and Z-Gly-OH in the presence of an activating reagent, silylating agent and a solvent
Data Source
AI summary
This disclosure describes compounds of Formula (I), stereoisomers, side compounds thereof, pharmaceutical compositions and methods of manufacturing such compounds, using silylation reagents and producing compositions and products made using such methods. More particularly, this disclosure describes manufacture of trofinetide and side products, compositions and products containing such compounds, for pharmaceutical uses to treat neurodegenerative or neurodevelopmental disorders.